Bruno V, Copani A, Battaglia G, Raffaele R, Shinozaki H, Nicoletti F
Institute of Pharmacology, University of Catania School of Medicine, Italy.
Eur J Pharmacol. 1994 Apr 11;256(1):109-12. doi: 10.1016/0014-2999(94)90624-6.
(2S,1'R,2'R,3'R)-2-(2,3-Dicarboxycyclopropyl)glycine (DCG-IV), a potent agonist of subtypes 2 and 3 of metabotropic glutamate receptors (mGluR2 or 3), protected cultured cortical neurons against excitotoxicity induced either by a brief exposure to N-methyl-D-aspartate (NMDA) or a prolonged exposure to kainate. As a neuroprotective agent, DCG-IV was much more potent than the mixed agonists 1S,3R-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) or (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine (L-CCG-I), suggesting a neuroprotective role for mGluR2 or 3 against excitotoxic neuronal death.
(2S,1'R,2'R,3'R)-2-(2,3-二羧基环丙基)甘氨酸(DCG-IV)是代谢型谷氨酸受体2型和3型(mGluR2或3)的强效激动剂,可保护培养的皮层神经元免受短暂暴露于N-甲基-D-天冬氨酸(NMDA)或长时间暴露于海人酸所诱导的兴奋性毒性。作为一种神经保护剂,DCG-IV比混合激动剂1S,3R-氨基环戊烷-1,3-二羧酸(1S,3R-ACPD)或(2S,1'S,2'S)-2-(羧基环丙基)甘氨酸(L-CCG-I)的效力要强得多,这表明mGluR2或3对兴奋性毒性神经元死亡具有神经保护作用。